Table 2.
18F-PSMA-1007 | 18F-FDG | |||||||
---|---|---|---|---|---|---|---|---|
n | SUVmax | SUVmean | TBR | n | SUVmax | SUVmean | TBR | |
urinary bladder | 21 | 2.40 (0.60–11.00) | 21 | 15.64(6.19–35.47) | ||||
obturator muscle | 21 | 0.70(0.35–0.92) | 21 | 0.75(0.57–1.64) | ||||
local lesion | 21 | 15.20 (6.20–75.00) | 8.70(3.80–43.00) | 24.92(8.41–117.06) | 14 | 4.20(2.80–10.50) | 2.80(1.60–6.30) | 4.82(1.00–14.00) |
metastase | 75 | 10.72 (1.42–79.70) | 6.67(0.89–50.16) | 13.3(1.61–96.02) | 54 | 4.42(1.05–12.41) | 2.59(0.86–7.81) | 7.91(1.28–96.02) |
benign lesions | 49 | 3.14(1.26–12.98) | 1.91(0.89–8.30) | 14 | 3.04(1.71–5.60) | 1.75(0.86–3.38) |
TBR, tumor-to-background ratio.